AUMED a.s. was established in 2007 and is now mainly engaged in research and development.. Its original focus has gradually begun to focus on the healthcare and pharmaceutical industries, where research and development activities are absolutely necessary due to new market requirements.

The company AUMED, a.s. focuses primarily on three research and development activities, specifically on the research and development of immunobiological preparations such as bacterial vaccines and immunomodulators, and then on the issue of bacteriophages. In recent years, the company has registered increased interest, especially from foreign business partners, in alternative medicinal products that would replace the current massive use of antibiotics.

Under the company AUMED, a.s. also include the subsidiaries AUMED Immunology a.s. and Aumed Pharma a.s.